Market Size of Strand Displacement Amplification Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 5.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Strand Displacement Amplification Market Analysis
The strand displacement amplification market is anticipated to register a CAGR of nearly 5.2% during the forecast period.
- The impact of COVID-19 on the studied market was significant as several strand displacement amplification-based products were developed to detect COVID-19. For instance, according to the study published in Nature Communications in August 2021, a non-enzymatic isothermal strand displacement and amplification (NISDA) was developed to detect SARS-CoV-2 RNA.
- A study was conducted to test its efficacy, and it was seen that in 164 clinical oropharyngeal RNA samples, the NISDA assay was 100 % specific, and it was 96.77% and 100% sensitive when used in the laboratory and hospital, respectively. Thus, the COVID-19 pandemic impacted the market significantly, as strand displacement amplification tests were developed to detect COVID-19. However, as the pandemic subsided, the studied market is expected to have normal growth during the forecast period of the study.
- Factors that are driving the market growth include increasing prevalence and incidence of infectious diseases such as tuberculosis and hepatitis, among others. Other factors that are driving the market growth include the rising prevalence of chronic diseases and the growing adoption of point-of-care testing.
- The rising prevalence of chronic and infectious diseases around the world is one of the major factors driving the market growth, as it will lead to the usage of more strand displacement amplification tests. For instance, according to the data published by the World Health Organization (WHO) in September 2022, a total of 348.9 thousand specimens were processed in China for influenza testing, out of which 49,260 cases were found to be positive. The source also stated that 211.6 thousand specimens were tested in Australia for influenza, out of which 11,311 cases turned out to be positive. Thus, the high prevalence of such infectious diseases is expected to boost the adoption of strand displacement amplification tests.
- Moreover, according to an article published by the WHO in 2022, an estimated 10.6 million around the world people fell ill with tuberculosis in 2021, which showed an increase of 4.5% from 10.1 million in the previous year. The source also stated that China accounted for 7.4% of tuberculosis cases around the world in 2021, which is the third highest.
- China is also considered a high-burden country for tuberculosis (TB), Human Immunodeficiency Virus (HIV) related TB, and Multidrug-resistant tuberculosis /rifampicin-resistant (MDR/RR-TB) from 2021 to 2025. Thus, the high prevalence of tuberculosis around the world is also expected to boost market growth.
- Additionally, the increasing demand for point-of-care testing is also expected to boost market growth, as it will lead to the increased usage of strand displacement amplification products. For instance, according to an article published by PubMed in March 2022, point-of-care testing (POCT) has been gaining attention as a tool that can provide immediate test results, and its adoption is increasing around the world.
- Hence, the factors above, such as the rising prevalence of chronic and infectious diseases and the growing adoption of point-of-care testing, are expected to enhance market growth. However, the disadvantages associated with the procedure and the availability of alternative procedures are expected to hinder market growth.